| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052050 | The Journal of Urology | 2005 | 4 Pages |
Abstract
From these results it is concluded that standardized mistletoe extract could be a potential alternative adjuvant therapy for superficial bladder cancer. Nevertheless, the optimal intravesical treatment regimen has yet to be defined.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
URSULA ELSÃSSER-BEILE, CHRISTIAN LEIBER, PHILIPP WOLF, MARTIN LUCHT, ULRICH MENGS, ULRICH WETTERAUER,